EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyse

Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: A systematic review and meta-analysis

Prayash Paudel, Asutosh Sah

Advances in Medical Sciences · 2026-09 · 71 (2) · 330-340

DOI: 10.1016/j.advms.2026.09.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Medical Sciences, 2026-09. Verfasst von Prayash Paudel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal. Electronic address: prayash.784401@mmc.t…. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Cervical cancer is a major global health burden, disproportionately affecting women in low- and middle-income countries (LMICs), where access to traditional human papillomavirus (HPV) screening is limited. Menstrual blood (MB), a non-invasive and passively collectable biospecimen, may offer a culturally acceptable alternative. This review evaluates the diagnostic accuracy of MB-based high-risk HPV detection compared to clinician-collected cervical samples. METHODS: We included diagnostic accuracy studies and randomized controlled trials (RCTs) evaluating self-collected MB for high-risk HPV detection in asymptomatic women aged 25-65 years. Eligible studies reported sensitivity, specificity, or 2×2 data using clinician-collected cervical samples as the reference. We searched PubMed, Embase, and Google Scholar up to July 7, 2025. Risk of bias was assessed via QUADAS-3, and a bivariate random-effects model estimated pooled sensitivity and specificity. Certainty of evidence was assessed using GRADE. RESULTS: Seven studies (n = 1297 participants; 586 reference-positive, 711 reference-negative) met inclusion criteria. The pooled sensitivity and specificity of MB-based HPV testing were 0.86 (95% CI: 0.80-0.90) and 0.90 (95% CI: 0.72-0.97), respectively. The diagnostic odds ratio was 56 (95% CI: 19-166), and the area under the hierarchical SROC curve was 0.90 (95% CI: 0.87-0.92), indicating high overall diagnostic performance. However, high heterogeneity (I2 = 94%) and threshold effects were observed. No significant publication bias was detected (Deeks' p = 0.62). CONCLUSIONS: MB-based HPV testing demonstrates high diagnostic accuracy and emerges as a non-invasive alternative for cervical cancer screening, especially in underserved settings. Further validation in diverse populations is warranted.

Schlagwörter

Stichwörter der Autor:innen

Early detection of cancerMenstruationPapillomavirus infectionsSensitivity and specificityUterine cervical neoplasms

Autor:innen und Institutionen

  • Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal. Electronic address: prayash.784401@mmc.tu.edu.np.
  • Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.

Zitieren

APA

Paudel, P., & Sah, A. (2026). Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: A systematic review and meta-analysis. Advances in Medical Sciences, 71(2), 330-340. https://doi.org/10.1016/j.advms.2026.09.004

Vancouver

Paudel P, Sah A. Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: A systematic review and meta-analysis. Advances in Medical Sciences. 2026;71(2):330-340. doi:10.1016/j.advms.2026.09.004

BibTeX
@article{Paudel2026,
  author = {Paudel, Prayash and Sah, Asutosh},
  title = {Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: A systematic review and meta-analysis},
  journal = {Advances in Medical Sciences},
  year = {2026},
  volume = {71},
  number = {2},
  pages = {330--340},
  doi = {10.1016/j.advms.2026.09.004}
}
Kostenlos starten →